INTREPIDA BIO
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer through drugs that alter the body’s first line of defense, innate immunity.
INTREPIDA BIO
Industry:
Biotechnology
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.intrepidabio.com
Total Employee:
1+
Status:
Closed
Total Funding:
9.5 M USD
Technology used in webpage:
SPF Apache PHP Apache 2.4 OpenSSL CentOS Liquid Web ParkLogic DNS
Similar Organizations
Atavistik Bio
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Venture Round - Intrepida Bio
Vertis SGR S.p.A.
Vertis SGR S.p.A. investment in Venture Round - Intrepida Bio
Indaco Venture Partners
Indaco Venture Partners investment in Venture Round - Intrepida Bio
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Intrepida Bio
Official Site Inspections
http://www.intrepidabio.com
- Host name: 104.21.80.1
- IP address: 104.21.80.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Intrepida Bio"
Intrepida Bio Company Profile 2024: Valuation, Funding
Intrepida Bio General Information Description. Developer of cancer medicines designed to modulate the innate immune system to fight cancer and other diseases. The company's …See details»
Intrepidabio
Oct 30, 2024 intrepidabio . Menu. Latest Cluster University of Jammu Syllabus 2024-2025. On October 30, 2024 October 30, 2024 by Intrepidabio. Central University of Jammu, is a part of …See details»
Intrepida Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Intrepida Bio, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, Technology Platform:Small …See details»
Intrepida Bio, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Intrepida Bio, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Press Release Distribution and Management - GlobeNewswire
SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Intrepida Bio, Inc. today debuts as a company dedicated to the discovery and development of medicines that modulate the innate …See details»
Intrepida Bio - VentureRadar
Intrepida Bio is a preclinical company dedicated to developing cures for cancer via drugs that alter the body’s first line of defense, the innate immune system. We are developing products …See details»
Intrepida Bio - Craft
Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases. The company designs proprietary monoclonal …See details»
Intrepida Bio - Contacts, Employees, Board Members ... - Crunchbase
IntrepidaBio is a preclinical biotechnology company. Start Free Trial . Chrome ExtensionSee details»
Intrepida Bio - Funding, Financials, Valuation & Investors
IntrepidaBio is a preclinical biotechnology company. Start Free Trial . Chrome ExtensionSee details»
Intrepidabio Security Rating - SecurityScorecard
Oct 25, 2024 Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases. The company designs proprietary …See details»
«Così è nata IntrepidaBio, la biotech col cuore italiano che vuole ...
Oct 31, 2019 L’operazione. IntrepidaBio sarà gestita da Joel F. Martin e Olivier Laurent, capo della ricerca scientifica, mentre Maria Caterina Turco, docente presso l’Università di Salerno e …See details»
Intrepida Bio - Products, Competitors, Financials, Employees ...
Intrepida Bio seeks to modulate the immune system to fight cancer and other diseases. The biotech emerged in late October with a $9.5 million equity investment from Sofinnova …See details»
Fighting cancer with biotech, IntrepidaBio at launch
IntrepidaBio was born from the acquisition of the technologies developed by Biouniversa, spinoff of the University of Salerno (Italy) by Dauntless, a Californian biotech company based in San …See details»
Intrepida Bio Launches to Develop Novel Medicines that
Oct 22, 2019 About Intrepida Bio Intrepida is dedicated to the discovery and development of medicines that modulate the innate immune system to fight cancer and other diseases. The …See details»
Intrepida Bio uncloaks with $9.5M and anti-BAG3 cancer programs …
Oct 22, 2019 That diamond, a program targeting the BAG3 protein to treat cancer, is the basis of Martin and Laurent’s new company, Intrepida Bio, which uncloaked with $9.5 million from …See details»
Intrepida Bio Launches to Develop Novel Medicines that
SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Intrepida Bio, Inc. today debuts as a company dedicated to the discovery and development of medicines that modulate the innate …See details»
Discovering Biotech Startups: A map for Selling to Intrepida Bio
Jun 3, 2020 Intrepida Bio’s Pipeline and R&D Focus Intrepida is dedicated to the discovery and development of medicines that modulate the innate immune system to fight cancer and other …See details»
Intrepida: Tackling the innate immune system to treat cancer
Oct 22, 2019 Intrepida Bio is developing first-in-class mAbs against BAG3 to modulate the TME. Inhua Muijrers-Chen, Associate Editor. October 22, 2019 12:03 PM UTC. Updated on Nov 5, …See details»